5 Biggest Diet/Weight Loss Companies in the World

In this article, we will be taking a look at the 5 biggest diet/weight loss companies in the world. To read our detailed analysis of these companies, you can go directly to see the 15 Biggest Diet/Weight Loss Companies in the World.

5. Peloton Interactive, Inc. (NASDAQ:PTON)

Estimated Valuation as of December 11: $3.91 billion

Peloton Interactive, Inc. (NASDAQ:PTON) operates an interactive fitness platform in North America and internationally. It is based in New York.

On November 21, John Blackledge placed a Market Perform rating on Peloton Interactive, Inc. (NASDAQ:PTON) shares.

Peloton Interactive, Inc. (NASDAQ:PTON) has over 5.9 million members on its fitness platform. It has reported revenues of $1.83 billion, and employees numbering 8,662 in 2021.

Merion Road Capital, an investment advisor, mentioned Peloton Interactive, Inc. (NASDAQ:PTON) in its third-quarter 2022 investor letter. Here’s what the firm said:

“Peloton Interactive, Inc. (NASDAQ:PTON) is quite a different story. You may recall from my Q1 letter that I initiated a position in the stock given the potential for a new CEO to leverage the company’s passionate and engaged userbase. The investment had meaningful upside potential (multiples of the then trading price), but also presented real downside risk; as such, I kept our exposure to just a few percentage points of the portfolio. Fast forward six months and underlying trends like churn, engagement, and new users weakened dramatically. I sold our shares as the likelihood for the company to achieve financial success has become increasingly remote.”

4. Planet Fitness, Inc. (NASDAQ:PLNT)

Estimated Valuation as of December 11: $6.71 billion

Planet Fitness, Inc. (NASDAQ:PLNT) franchises and operates fitness centers under the Planet Fitness brand. It is based in Hampton, New Hampshire.

Cowen’s Max Rakhlenko holds an Outperform rating on Planet Fitness, Inc. (NASDAQ:PLNT) shares as of November 16.

Planet Fitness, Inc. (NASDAQ:PLNT) has about 2,039 locations and 1,616 employees as of 2020. The company is working on expanding this year, acquiring over 100 fitness centers in expectation of a massive return to gyms post-pandemic. It is arguably one of the largest companies in the weight management industry.

3. Amgen, Inc. (NASDAQ:AMGN)

Estimated Valuation as of December 11: $148.68 billion

Amgen, Inc. (NASDAQ:AMGN) is a biotech company based in Thousand Oaks, California. In the weight loss sector, the company’s weight-loss hormone, Leptin, has been incredibly successful in helping dieters control their appetite and manage their weight.

On December 13, Christopher Raymond at Piper Sandler reiterated an Overweight rating on Amgen, Inc. (NASDAQ:AMGN) shares.

Amgen, Inc. (NASDAQ:AMGN) had a net income of $5.89 billion and revenues of $25.98 billion as of 2021. By 2020, the company had about 24,300 employees.

Smead Capital Management, an investment management company, mentioned Amgen, Inc. (NASDAQ:AMGN) in its third-quarter 2022 investor letter. Here’s what the firm said:

“Two things are very noticeable right off the top. First, sometimes you have to be happy losing less in a bear market environment so that you have more of your capital to grow in the next bull market. We are never really happy losing money. Second, 2022 is likely to be our third year of existence as a fund to lose money for the year. This year would join 2008 and 2018 in this undistinguished category. Our biggest detractors was dominated by  Amgen (NASDAQ:AMGN). Consumer/investor fears about media and e-commerce hit WBD and EBAY and profit taking in Amgen came from early 2022 strength.”

2. NIKE, Inc. (NYSE:NKE)

Estimated Valuation as of December 11: $171.2 billion

NIKE, Inc. (NYSE:NKE) is a footwear company based in Beaverton, Oregon. The company’s athletic footwear and line of running shoes, yoga equipment, sports equipment, and more facilitate weight loss and fitness for many customers.

An Outperform rating was reiterated on NIKE, Inc. (NYSE:NKE) shares on December 7 by analyst Piral Dadhania at RBC Capital.

NIKE, Inc. (NYSE:NKE) had revenues of about $46.71 billion in 2022, and an operating income of $6.86 billion. The company’s net income was $6.05 billion, and its total assets stood at $40.32 billion.

1. Eli Lilly and Company (NYSE:LLY)

Estimated Valuation as of December 11: $343 billion

Eli Lilly and Company (NYSE:LLY) is a healthcare company based in Indianapolis, Indiana. The company has several weight loss drugs approved for distribution, such as tirzepatide.

Colin Bristow at UBS holds a Buy rating on Eli Lilly and Company (NYSE:LLY) shares as of December 13.

This April, Eli Lilly and Company (NYSE:LLY) reported that its new weight-loss drug, tirzepatide, has the ability to deliver up to 22.5% weight loss in adults suffering from obesity. The company had generated revenues of $28.32 billion by 2021, and had a net income of $5.58 billion as well.

See also 10 Best Halal Dividend Stocks To Buy and 10 Best Quantum Computing Stocks To Buy.